Roivant Sciences (ROIV) Other financing activities (2020 - 2026)

Roivant Sciences (ROIV) has 4 years of Other financing activities data on file, last reported at $1.2 million in Q4 2025.

• Quarterly Other financing activities fell 96.88% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $38.9 million (down 59.83% YoY) and the FY2025 annual result came in at $49.6 million, up 991840.0% from the prior year.
• Other financing activities advanced to $1.2 million in Q4 2025, from -$29.3 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $51.0 million in Q4 2023 to a low of -$29.3 million in Q3 2025.
• A 3-year average of $11.0 million and a median of $6.6 million in 2024 frame the typical range for Other financing activities.
• The widest YoY moves for Other financing activities: up 1223.51% in 2025, down 542.34% in 2025.
• Tracing ROIV's Other financing activities over 3 years: stood at $51.0 million in 2023, then dropped by 27.47% to $37.0 million in 2024, then tumbled by 96.88% to $1.2 million in 2025.
• The last three Other financing activities figures came in at $1.2 million (Q4 2025), -$29.3 million (Q3 2025), and $30.1 million (Q2 2025), per Business Quant data.